Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 11/2015

01.11.2015 | Original Article

Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors

verfasst von: Laura Prakash, Jeffrey E. Lee, James Yao, Priya Bhosale, Aparna Balachandran, Huamin Wang, Jason B. Fleming, Matthew H. G. Katz

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Venous tumor thrombi have been reported in as many as 33 % of patients with pancreatic neuroendocrine tumors (pNETs). Surgical thrombectomy is often used to manage tumor thrombi that develop in association with cancers of the liver or kidney. We have likewise used thrombectomy to extract portal venous tumor thrombi in selected cases of pNET.

Methods

We describe all cases of portal venous thrombectomy that were performed at our institution between 2007 and 2014 and illustrate the thrombectomy techniques we used in detail. In addition, we report the results of a PubMed search for English-language articles that were published between 1990 and 2014 and that described surgical therapy for portal venous thrombus developing in association with pNETs.

Results

Among 245 patients with pNET that underwent pancreatectomy at our institution, 26 (11 %) patients required surgical management of tumor involvement of the portal vein or its tributaries concomitant with pancreatectomy, including 9 (3.8 %) patients who underwent portal venous tumor thrombectomy. Eight cases describing surgical management of tumor thrombus including two additional cases of portal venous tumor thrombectomy were identified in the medical literature. Among patients with pNET who underwent thrombectomy at our institution, all nine had non-functioning tumors and eight (89 %) had tumors of the body and/or tail of the pancreas. Six (67 %) were treated with systemic therapy prior to pancreatectomy. Seven (78 %) patients are alive at a median follow-up of 33 months (range 3 to 97).

Conclusion

Venous tumor thrombectomy may be used to safely and effectively extract thrombi from the portal venous system in selected patients with advanced pNET concomitant with pancreatectomy.
Literatur
1.
Zurück zum Zitat Yao, J.C., et al., Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience. Cancer Res, 2013. 73(5): p. 1449–53.CrossRefPubMed Yao, J.C., et al., Everolimus in advanced pancreatic neuroendocrine tumors: the clinical experience. Cancer Res, 2013. 73(5): p. 1449–53.CrossRefPubMed
2.
Zurück zum Zitat Balachandran, A., et al., Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. AJR Am J Roentgenol, 2012. 199(3): p. 602–8.CrossRefPubMed Balachandran, A., et al., Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. AJR Am J Roentgenol, 2012. 199(3): p. 602–8.CrossRefPubMed
3.
Zurück zum Zitat Kawakami, H., et al., Pancreatic Endocrine Tumors with Intraductal Growth into the Main Pancreatic Duct and Tumor Thrombus within the Portal Vein: A Case Report and Review of the Literature. Internal Medicine, 2007. 46(6): p. 273–277.CrossRefPubMed Kawakami, H., et al., Pancreatic Endocrine Tumors with Intraductal Growth into the Main Pancreatic Duct and Tumor Thrombus within the Portal Vein: A Case Report and Review of the Literature. Internal Medicine, 2007. 46(6): p. 273–277.CrossRefPubMed
4.
Zurück zum Zitat Chok, K.S., et al., Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg, 2014. 38(2): p. 490–6.CrossRefPubMed Chok, K.S., et al., Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg, 2014. 38(2): p. 490–6.CrossRefPubMed
5.
Zurück zum Zitat Minagawa, M. and M. Makuuchi, Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol, 2006. 12(47): p. 7561–7.PubMedCentralPubMed Minagawa, M. and M. Makuuchi, Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol, 2006. 12(47): p. 7561–7.PubMedCentralPubMed
6.
Zurück zum Zitat Ali, A.S., et al., The surgical management and prognosis of renal cell cancer with IVC tumor thrombus: 15-years of experience using a multi-specialty approach at a single UK referral center. Urol Oncol, 2013. 31(7): p. 1298–304.CrossRefPubMed Ali, A.S., et al., The surgical management and prognosis of renal cell cancer with IVC tumor thrombus: 15-years of experience using a multi-specialty approach at a single UK referral center. Urol Oncol, 2013. 31(7): p. 1298–304.CrossRefPubMed
7.
Zurück zum Zitat Ciancio, G., A.S. Livingstone, and M. Soloway, Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol, 2007. 51(4): p. 988–94; discussion 994–5.CrossRefPubMed Ciancio, G., A.S. Livingstone, and M. Soloway, Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. Eur Urol, 2007. 51(4): p. 988–94; discussion 994–5.CrossRefPubMed
8.
Zurück zum Zitat Akin, O., D. Dixit, and L. Schwartz, Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging, 2011. 36(1): p. 62–8.CrossRefPubMed Akin, O., D. Dixit, and L. Schwartz, Bland and tumor thrombi in abdominal malignancies: magnetic resonance imaging assessment in a large oncologic patient population. Abdom Imaging, 2011. 36(1): p. 62–8.CrossRefPubMed
9.
Zurück zum Zitat Barbier, L., et al., Pancreatic endocrine tumor with neoplastic venous thrombus and bilobar liver metastasis. A case report. J Visc Surg, 2010. 147(1): p. e58-62.CrossRefPubMed Barbier, L., et al., Pancreatic endocrine tumor with neoplastic venous thrombus and bilobar liver metastasis. A case report. J Visc Surg, 2010. 147(1): p. e58-62.CrossRefPubMed
10.
Zurück zum Zitat Bedirli, A., et al., Portal vein resection for a portal vein thrombus caused by nonfunctioning islet cell carcinoma: report of a case. Surg Today, 2004. 34(9): p. 802–4.CrossRefPubMed Bedirli, A., et al., Portal vein resection for a portal vein thrombus caused by nonfunctioning islet cell carcinoma: report of a case. Surg Today, 2004. 34(9): p. 802–4.CrossRefPubMed
11.
Zurück zum Zitat Obuz, F., S. Bora, and S. Sarioglu, Malignant islet cell tumor of the pancreas associated with portal venous thrombus. Eur Radiol, 2001. 11(9): p. 1642–4.CrossRefPubMed Obuz, F., S. Bora, and S. Sarioglu, Malignant islet cell tumor of the pancreas associated with portal venous thrombus. Eur Radiol, 2001. 11(9): p. 1642–4.CrossRefPubMed
12.
Zurück zum Zitat Rodriguez, R.A., H. Overton, and K.T. Morris, Pancreatic neuroendocrine tumor with splenic vein tumor thrombus: A case report. Int J Surg Case Rep, 2014. 5(12): p. 1271–4.PubMedCentralCrossRefPubMed Rodriguez, R.A., H. Overton, and K.T. Morris, Pancreatic neuroendocrine tumor with splenic vein tumor thrombus: A case report. Int J Surg Case Rep, 2014. 5(12): p. 1271–4.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Watase, M., et al., A case of splenic vein occlusion caused by the intravenous tumor thrombus of nonfunctioning islet cell carcinoma. Surg Today, 1992. 22(1): p. 62–5.CrossRefPubMed Watase, M., et al., A case of splenic vein occlusion caused by the intravenous tumor thrombus of nonfunctioning islet cell carcinoma. Surg Today, 1992. 22(1): p. 62–5.CrossRefPubMed
14.
Zurück zum Zitat Yamamoto, H., et al., A nonfunctioning islet cell carcinoma with tumor thrombus in both the portal and splenic veins—a case report of successful resection. Journal of Hepato-Biliary-Pancreatic Surgery, 1995. 2(2): p. 184–189.CrossRef Yamamoto, H., et al., A nonfunctioning islet cell carcinoma with tumor thrombus in both the portal and splenic veins—a case report of successful resection. Journal of Hepato-Biliary-Pancreatic Surgery, 1995. 2(2): p. 184–189.CrossRef
15.
Zurück zum Zitat Yamato, H., et al., Pancreatic Carcinoma Associated with Portal Vein Tumor Thrombus: Three Case Reports. Internal Medicine, 2009. 48(3): p. 143–150.CrossRefPubMed Yamato, H., et al., Pancreatic Carcinoma Associated with Portal Vein Tumor Thrombus: Three Case Reports. Internal Medicine, 2009. 48(3): p. 143–150.CrossRefPubMed
16.
Zurück zum Zitat Catalano, O.A., et al., Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology, 2010. 254(1): p. 154–62.CrossRefPubMed Catalano, O.A., et al., Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology, 2010. 254(1): p. 154–62.CrossRefPubMed
17.
Zurück zum Zitat Sandrasegaran, K., et al., Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol, 2013. 201(6): p. 1211–9.CrossRefPubMed Sandrasegaran, K., et al., Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients. AJR Am J Roentgenol, 2013. 201(6): p. 1211–9.CrossRefPubMed
18.
Zurück zum Zitat Daveson, J., et al., A case of an isolated gastric variceal bleed secondary to a pancreatic neuroendocrine tumour. Eur J Gastroenterol Hepatol, 2007. 19(12): p. 1144–8.CrossRefPubMed Daveson, J., et al., A case of an isolated gastric variceal bleed secondary to a pancreatic neuroendocrine tumour. Eur J Gastroenterol Hepatol, 2007. 19(12): p. 1144–8.CrossRefPubMed
19.
Zurück zum Zitat Dedania, N., et al., Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer. J Gastrointest Surg, 2013. 17(8): p. 1392–8.CrossRefPubMed Dedania, N., et al., Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer. J Gastrointest Surg, 2013. 17(8): p. 1392–8.CrossRefPubMed
20.
Zurück zum Zitat Kouvaraki, M.A., et al., Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol, 2004. 22(23): p. 4762–71.CrossRefPubMed Kouvaraki, M.A., et al., Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas. J Clin Oncol, 2004. 22(23): p. 4762–71.CrossRefPubMed
21.
Zurück zum Zitat Valle, J.W., et al., A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours. Cancer Treat Rev, 2014. 40(3): p. 376–89.CrossRefPubMed Valle, J.W., et al., A systematic review of non-surgical treatments for pancreatic neuroendocrine tumours. Cancer Treat Rev, 2014. 40(3): p. 376–89.CrossRefPubMed
22.
Zurück zum Zitat Strosberg, J.R., et al., First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer, 2011. 117(2): p. 268–75.CrossRefPubMed Strosberg, J.R., et al., First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas. Cancer, 2011. 117(2): p. 268–75.CrossRefPubMed
Metadaten
Titel
Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors
verfasst von
Laura Prakash
Jeffrey E. Lee
James Yao
Priya Bhosale
Aparna Balachandran
Huamin Wang
Jason B. Fleming
Matthew H. G. Katz
Publikationsdatum
01.11.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 11/2015
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-015-2914-0

Weitere Artikel der Ausgabe 11/2015

Journal of Gastrointestinal Surgery 11/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.